NYSE:GBS GBS Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding GBS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.66 0.00 (-0.30%) (As of 07/1/2022 09:48 AM ET) Add Compare Share Today's Range$0.66▼$0.6750-Day Range$0.56▼$0.7952-Week Range$0.38▼$5.11Volume100 shsAverage Volume87,341 shsMarket Capitalization$9.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media GBS MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares$12,992 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.63) to ($0.31) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.0.55 out of 5 stars 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for GBS. Previous Next 0.0 Short Interest Short InterestThere is no current short interest data available for GBS. Previous Next 0.0 Dividend Strength Dividend YieldGBS does not currently pay a dividend.Dividend GrowthGBS does not have a long track record of dividend growth. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for GBS. Previous Next 1.3 News and Social Media Coverage News SentimentGBS has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for GBS this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for GBS on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added GBS to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, GBS insiders have bought more of their company's stock than they have sold. Specifically, they have bought $12,992.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 0.27% of the stock of GBS is held by insiders.Percentage Held by InstitutionsOnly 1.63% of the stock of GBS is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for GBS are expected to grow in the coming year, from ($0.63) to ($0.31) per share. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive GBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter. Email Address About GBS (NYSE:GBS) StockGBS Inc. operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company also focuses on developing COV2 test, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumour markers, hormones, and nucleic acid diagnostic modalities. It has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Read More GBS Stock News HeadlinesJuly 5, 2022 | msn.comDoctors couldn't diagnose him, then they found he has this rare diseaseJune 27, 2022 | finance.yahoo.comInaugural Hong Kong Science Fair Celebrates Hong Kong's Young InnovatorsJune 22, 2022 | finance.yahoo.comGBS: GBS’ Prints Are All Over ItJune 16, 2022 | finance.yahoo.comGBS INC. Announces Adjournment of 2022 Annual Meeting of Stockholders to July 13, 2022June 16, 2022 | seekingalpha.comGBS stock rises 10% on exclusive agreement to acquire Intelligent FingerprintingJune 16, 2022 | finance.yahoo.comGBS Inc. Enters into Exclusivity Agreement for an Acquisition of Unique Point of Care Diagnostic Screening Technology Focused on Opioids and Drugs of AbuseJune 14, 2022 | msn.comI thought I had food poisoning - until I stopped being able to move body partsJune 12, 2022 | msn.comQadam Qadam Badhaye Ja: Jammu man braves paralysis to realise Army dreamJune 11, 2022 | msn.comBraveheart beats paralysis to realise his Army dreamJune 7, 2022 | finance.yahoo.comSino Group and EcoBricks Jointly Launch Breakthrough Solution to Upcycle Plastic Waste into Sustainable Construction Materials - Yahoo FinanceMay 26, 2022 | fool.comDXC Technology Company (DXC) Q4 2022 Earnings Call Transcript - The Motley FoolMay 23, 2022 | globenewswire.comTODAY: Gb Sciences' President and Chief Science Officer Presents Keynote Address on Cannabinoid-Containing Formulations for Parkinson's Disease at 2022 NeuroForum Summit - GlobeNewswireMay 18, 2022 | finance.yahoo.comGBS Inc. to Present at the H.C. Wainwright Global Investment Conference - Yahoo FinanceMay 16, 2022 | globenewswire.comGBS Inc. to Present at the HC Wainwright Global Investment Conference - GlobeNewswireMay 16, 2022 | finance.yahoo.comGBS: Third Quarter Fiscal Year 2022 Operational and Financial Results - Yahoo FinanceMay 16, 2022 | finance.yahoo.comGBS: Third Quarter Fiscal Year 2022 Operational and Financial ResultsMay 16, 2022 | finance.yahoo.comGBS Inc. to Present at the H.C. Wainwright Global Investment ConferenceMay 16, 2022 | finance.yahoo.comThe Global E-learning Market is expected to grow by $ 1.72 tn during 2022-2026, accelerating at a CAGR of 16.35% during the forecast period - Yahoo FinanceMay 14, 2022 | seekingalpha.comGBS Inc.'s (GBS) CEO Dr. Steven Boyages on Q3 2022 Results - Earnings Call Transcript - Seeking AlphaMay 13, 2022 | benzinga.comGBS Inc. to Hold Virtual 2022 Annual Shareholder Meeting on Thursday, June 16, 2022, at 4:00pm ET - Benzi - BenzingaMay 13, 2022 | finance.yahoo.comGBS Inc. to Hold Virtual 2022 Annual Shareholder Meeting on Thursday, June 16, 2022, at 4:00pm ETMay 12, 2022 | globenewswire.comTODAY: Gb Sciences Showcases Its PhAROS™ Drug Discovery Platform at the 2nd ALCOR Drug Discovery Platform Summit - GlobeNewswireMay 10, 2022 | finance.yahoo.comGBS Inc. Reports Third Quarter 2022 Financial Results and Recent Business HighlightsMay 10, 2022 | forbes.comStrategies To Expand Labor Pools Today And In A Recession - ForbesMay 9, 2022 | businesswire.comHCL Technologies to Acquire Digital Banking and Wealth Management Specialist Confinale - Business WireSee More Headlines Industry, Sector and Symbol Stock ExchangeNYSE Industry N/A Sub-IndustryN/A SectorMedical Current SymbolNYSE:GBS CUSIPN/A CIK1725430 Webwww.gbs.inc Phone646 828 8258FaxN/AEmployees7Year FoundedN/ACompany Calendar Last Earnings5/10/2022Today7/05/2022Fiscal Year End6/30/2023Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.98 million Price / Sales4.96 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares14,890,000Free Float14,850,000Market Cap$9.83 million OptionableNot Optionable Beta0.91 GBS Frequently Asked Questions How has GBS's stock price performed in 2022? GBS's stock was trading at $1.4350 on January 1st, 2022. Since then, GBS shares have decreased by 54.0% and is now trading at $0.66. View the best growth stocks for 2022 here. How were GBS's earnings last quarter? GBS Inc. (NYSE:GBS) announced its quarterly earnings results on Tuesday, May, 10th. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.07. The firm had revenue of $0.19 million for the quarter. View GBS's earnings history. Who are GBS's key executives? GBS's management team includes the following people: Dr. Stephen Constantine Boyages M.D., MBBS, Ph.D., Interim CEO & Chairman (Age 64, Pay $20.51k)Mr. Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law, Chief Financial Officer (Age 60, Pay $265.58k) (LinkedIn Profile)Mr. Harry Simeonidis, Pres of Asia Pacific - Sales & Marketing (Age 54, Pay $350.69k)Ms. Victoria Gavrilenko, Operations Mang. (Age 39)Mr. Alex Arzeno, VP of Investor Relations Who are some of GBS's key competitors? Some companies that are related to GBS include SANUWAVE Health (SNWV), Bionomics (BNOX), Celyad Oncology (CYAD), Intelligent Ultrasound Group plc (MED.L) (MED), Cocrystal Pharma (COCP), Iterum Therapeutics (ITRM), ZIVO Bioscience (ZIVO), NantHealth (NH), Intelligent Ultrasound Group (IUG), Acurx Pharmaceuticals (ACXP), Alimera Sciences (ALIM), GlucoTrack (GCTK), Purple Biotech (PPBT), Integrity Applications (IGAP) and NexImmune (NEXI). View all of GBS's competitors. What is GBS's stock symbol? GBS trades on the New York Stock Exchange (NYSE) under the ticker symbol "GBS." How do I buy shares of GBS? Shares of GBS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is GBS's stock price today? One share of GBS stock can currently be purchased for approximately $0.66. How much money does GBS make? GBS (NYSE:GBS) has a market capitalization of $9.83 million and generates $1.98 million in revenue each year. How many employees does GBS have? GBS employs 7 workers across the globe. How can I contact GBS? The official website for GBS is www.gbs.inc. The company can be reached via phone at 646 828 8258. This page (NYSE:GBS) was last updated on 7/5/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
